Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Drugs for Solid Tumors with Gene Alterations

Jemperli (dostarlimab-gxly) Injection

Drug company: GlaxoSmithKline
844-447-5662

GSK Oncology offers 2 financial assistance programs for patients using Jemperli:

Together with GSK Oncology Co-pay Program

Jemperli Patient Assistance Program

Keytruda (pembrolizumab)

Drug company: Merck
855-257-3932

Merck offers 2 financial assistance programs for patients who have been prescribed Keytruda:

Merck Co-pay Assistance Program

Merck Patient Assistance Program

Pedmark (sodium thiosulfate) Injection

Drug company: Fennec Pharmaceuticals
833-773-3627

Fennec Pharmaceuticals offers 4 financial assistance programs for patients using Pedmark:

Pedmark Copay Savings Program

Patient Assistance Program

Quick Start Program

Bridge Program

Retevmo (selpercatinib) Capsules

Drug company: Eli Lilly
866-472-8663

Eli Lilly offers 2 financial assistance programs for patients using Retevmo:

Retevmo Savings Card

Lilly Cares Foundation Patient Assistance Program

Rozlytrek (entrectinib) Capsules

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients who have been prescribed Rozlytrek:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Tafinlar (dabrafenib) Capsules & Mekinist (trametinib) Tablets

Drug company: Novartis
800-282-7630

Novartis Patient Assistance NOW Oncology offers 2 financial assistance programs for patients using the combination of Tafinlar and Mekinist:

Novartis Oncology Universal Co-pay Program

Novartis Patient Assistance Foundation

Vitrakvi (larotrectinib) Capsules/Oral Solution

Drug company: Bayer
844-634-8725

Bayer offers 2 financial assistance programs for patients who have been prescribed Vitrakvi:

VITRAKVI $0 Co-Pay Program

Bayer US Patient Assistance Foundation